Tag: generic pharmaceuticals global market

  • Evaluating the Generic Pharmaceuticals Market’s Growth Prospects from 2024 to 2033

    Evaluating the Generic Pharmaceuticals Market’s Growth Prospects from 2024 to 2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How is the Growth Rate of the Generic Pharmaceuticals Market Estimated for 2024-2033?

    The generic drugs market has experienced robust growth in the past few years. The market, valued at $381 billion in 2023, is projected to expand to $402.97 billion in 2024 with a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth during the historical period include increased awareness and spending in healthcare, expiration of drug patents, a rise in cases of respiratory diseases, lifestyle changes, a greater number of surgical procedures, robust economic growth in emerging markets, broadening insurance coverage, a surge in the aged population, and an increased number of approvals.

    The growth of the generic pharmaceuticals market is forecasted to be robust in the coming years, ballooning to a size of $514.81 billion in 2028 with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to this projected growth during the forecast period include escalated prevalence of chronic illnesses, increased support from governmental regulators, the application of novel drug discovery and drug delivery techniques, burgeoning healthcare expenditure, growing elderly population, and strong patents on significant drugs. The forecast period will also witness trending developments like the escalating usage of 3D printing, the incorporation of artificial intelligence (AI) in procedures, the utilization of biomarkers for drug creation, partnerships to catalyze innovation, combination drug treatment, alterations of existing epilepsy medications, and the ascendance of generic respiratory drugs.

    Claim Your Free Sample of the Global Generic Pharmaceuticals Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2479&type=smp

    What Key Drivers Are Propelling the generic pharmaceuticals Market’s Growth?

    The increasing occurrence of long-term illnesses has become a major factor propelling the growth of the generic pharmaceuticals market. The diagnosed cases of chronic diseases are on the rise, causing an increased demand for treatment drugs. Branded drugs are often sold at a high cost, whereas generic drugs provided at a lower price have identical chemical ingredients. This price difference, along with the same chemical constituents and strength, motivates a patient to opt for generic drugs over branded ones. Chronic diseases warrant prolonged treatment, inevitably enhancing the sales of generic drugs. As noted by the World Health Organization (WHO), the coming 10 years will witness a 17% surge in deaths caused by chronic diseases.

    What Are the Distinct Segments of the Generic Pharmaceuticals Market?

    1) By Type: Biosimilars, Generics

    2) By Drug Delivery: Oral, Injectables, Dermal/Topical, Inhaled

    3) By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies

    Which New Trends Are Making Waves in the Generic Pharmaceuticals Market?

    3D printing technology holds the potential to revolutionise the production process in the generic pharmaceuticals market. It can facilitate improvements in R&D efficiency and provide new advantages to patients. 3D printing enables drug manufacturers to create medications with tailored size, shape, and texture, something unachievable with conventional manufacturing methods. It also makes it possible for manufacturers to design generic drugs with varying release dates, visual aspects, and flavours. For instance, GlaxoSmithKline (GSK) conducted a study where they utilised ultraviolet (UV) and 3D printing to produce tablets for Parkinson’s disease treatment. Martin Wallace, the director of GSK Technology, stated that GSK is dedicated to investing in 3D printing for pill and tablet manufacturing. Plus, ‘ZipDose’, a technology developed by Aprecia pharmaceutical company for 3D printed drug production, was launched.

    Order Now for Fast Delivery of Your Generic Pharmaceuticals Market Report!

    https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

    Which Regions Are Significant to the Growth of the Generic Pharmaceuticals Market?

    North America was the largest region in the generic pharmaceuticals market in 2023. Middle East is expected to be the fastest-growing region in the generic pharmaceuticals market report during the forecast period. The regions covered in the generic pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Generic Pharmaceuticals Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the generic pharmaceuticals market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Generic Pharmaceuticals Market Include

    1. Generic Pharmaceuticals Market Executive Summary

    2. Generic Pharmaceuticals Market Segments

    3. Generic Pharmaceuticals Market Size And Template Market Growth Rate

    4. Key Generic Pharmaceuticals Market Trends

    5. Major Generic Pharmaceuticals Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market

    26. Top Generic Pharmaceuticals Companies

    27. Generic Pharmaceuticals Market Opportunities And Strategies

    28. Generic Pharmaceuticals Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Pharmaceutical Sterility Testing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

    Pharmaceutical Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

    Pharmaceutical Glass Packaging Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmaceutical-glass-packaging-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Generic Pharmaceuticals Market 2024

    5 Key Insights On The Generic Pharmaceuticals Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Generic Pharmaceuticals Global Market Report 2024, the generic pharmaceuticals market is expected to show significant growth in the forecast period.

    The generic pharmaceuticals market is experiencing a robust surge, driven by various factors influencing its trajectory. Let’s delve into the dynamics propelling this market forward and explore the innovations shaping its future.

    Steady Growth Trajectory: A Snapshot

    • In 2023, the generic pharmaceuticals market stood at $381 billion.
    • By 2024, it is expected to reach $402.97 billion, showcasing a compound annual growth rate (CAGR) of 5.8%.
    • Forecasts predict further expansion, with the market projected to hit $514.81 billion by 2028, boasting a CAGR of 6.3%.

    Driving Forces Behind Market Growth
    Rising Incidence of Chronic Diseases

    • The surge in chronic diseases is a primary driver, compelling individuals to seek affordable treatment options.
    • Generic drugs offer the same composition as branded counterparts at a lower cost, making them increasingly attractive.
    • With chronic illnesses necessitating prolonged treatment, the demand for generic drugs continues to rise.

    Supportive Regulatory Environment

    • Regulators are increasingly endorsing the generic pharmaceuticals market, fostering its growth.
    • Favorable regulations facilitate the development and approval of generic drugs, expanding market opportunities.

    Technological Innovations

    • Advancements in drug discovery, delivery, and monitoring methods contribute to market expansion.
    • Technologies like 3D printing revolutionize manufacturing, enabling customization of drugs’ size, shape, and release profiles.

    Strategic Collaborations

    • Collaborative efforts drive innovation within the generic pharmaceuticals sector.
    • Partnerships between pharmaceutical companies spur the development of novel therapies and delivery mechanisms.

    View More On The Generic Pharmaceuticals Market Report 2024 – https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

    Key Trends Shaping the Future
    Integration of 3D Printing Technology

    • 3D printing presents novel opportunities for drug manufacturing, allowing for customized formulations.
    • Examples include GlaxoSmithKline’s study on 3D-printed tablets for Parkinson’s disease treatment.

    Strategic Acquisitions

    • Acquisitions, such as Hikma Pharmaceuticals PLC’s purchase of Custopharm Inc., bolster market players’ portfolios and R&D capabilities.
    • This acquisition enhances Hikma’s US portfolio significantly, reflecting strategic expansion efforts.

    Market Segmentation and Regional Outlook
    Segmentation Overview

    1. Type: Biosimilars, Generics
    2. Drug Delivery: Oral, Injectables, Dermal/Topical, Inhaled
    3. Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others
    4. Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Regional Insights

    • North America led the generic pharmaceuticals market in 2023, while the Middle East is poised for rapid growth.
    • Market dynamics vary across regions, influenced by factors such as regulatory landscapes and healthcare infrastructure.

    Conclusion: Embracing Innovation for Sustained Growth
    The generic pharmaceuticals market continues to expand, driven by evolving healthcare needs and technological advancements. As the industry embraces innovations like 3D printing and strengthens strategic partnerships, it is poised for sustained growth. With a focus on affordability, accessibility, and efficacy, stakeholders are reshaping the landscape of generic drug development and delivery, ensuring a brighter and healthier future for global healthcare.

    Request A Sample Of The Global Generic Pharmaceuticals Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=2479&type=smp